Zephyrus Innovations, a privately held medical device company specializing in safety syringes and Closed System Transfer Devices (CSTDs), has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new VaporShield™ CSTD.
As the newest addition to Zephyrus’s line of safety syringes, the VaporShield™ CSTD is designed to protect healthcare workers from exposure to hazardous drugs, in compliance with USP <800> standards.
Currently, there are no devices on the market that fully address safety requirements for healthcare professionals administering subcutaneous or intramuscular injections.
VaporShield™ offers a completely closed system from drug preparation to injection and disposal, while retaining the safety features of the Aeroject™ auto-retractable syringe, which helps prevent needlestick injuries.
By providing enhanced protection during subcutaneous and intramuscular drug administration, VaporShield™ marks an important step forward in healthcare worker safety.
Its development underscores Zephyrus’s commitment to creating innovative, practical solutions that improve both safety and regulatory compliance in clinical practice.
